Arterial Occlusion, CTS, Ischemic Stroke, Magnetic Resonance Imaging
Conditions
Brief summary
To study the feasibility and usefulness of multimodal MR compared to multimodal CT to select patients with acute ischemic stroke and favorable clinical outcome after mechanical thrombectomy. The specific objectives are to compare (1) the door-picture time and door-groin puncture time, (2) the rate of patients with acute stroke selected for endovascular treatment and (3) the safety and clinical response after thrombectomy between the two groups selected according to the imaging modality. Methodology: Single-center, randomized 1:1 and stratified by age and NIHSS study of consecutive patients with suspected acute ischemic stroke. Occlusion site, ischemic volume (core) and perfusion volume will be studied by an automated perfusion system (RAPID software) in both neuroimaging groups. Mechanical thrombectomy criteria will be basically based on the presence of a Large Vessel Occlusion (LVO) and a volume of core lower than 70cc in the Cerebral Blood Flow (CBF) or Diffusion Weighted Image (DWI) sequences. Modified Rankin scale at 90 days and the rate of intracranial hemorrhage and mortality will be considered as variables of response.
Detailed description
In acute ischemic stroke, arterial occlusion lead to a brain ischemia that will progress to brain death of the ischemic area if the clot is not rapidly removed. Advanced neuroimaging can help us to distinguish between the irreversible injury brain parenchyma or core and the potential reversible ischemic tissue or penumbra. Multimodal neuroimaging techniques (MR and CT) have been developed in order to distinguish between core and penumbra areas and have been used to select patients in most of the last randomized clinical trials that have demonstrated the benefit of endovascular treatment. There is no agreement about which multimodal technique offers a better information to select patients for endovascular treatment. The main aim is to study the feasibility and usefulness of multimodal MR compared to multimodal CT to select patients with acute ischemic stroke and favorable clinical outcome after mechanical thrombectomy. The specific objectives are: Primary: to confirm no differences in long-term clinical outcome in patients with acute ischemic stroke and in those treated with endovascular therapy selected by multimodal CT or MR; and Secondary: (1) compare the feasibility of both techniques in this setting, (2) the door-picture time and door-groin puncture time of both techniques, (3) the safety of both techniques (sICH and in-hospital pneumonia) Methodology: Single-center, randomized (1:1) and stratified by age and NIHSS study of consecutive patients with acute ischemic stroke. Occlusion site, ischemic volume (core) and perfusion volume will be studied by an automated perfusion system (RAPID software) in both neuroimaging groups. Mechanical thrombectomy criteria will be basically based on the presence of an intracranial LVO occlusion and a volume of core lower than 70cc in the CBF or DWI sequences. Modified Rankin scale at 90 days and the rate of intracranial hemorrhage and mortality will be considered as variables of response.
Interventions
DIAGNOSTIC_TESTMULTIMODAL MAGNETIC RESONANCE (Multimodal MR)
After randomization, a MULTIMODAL MR will be performed to select treatment patient
DIAGNOSTIC_TESTMULTIMODAL COMPUTERIZED TOMOGRAPHY (Multimodal CT)
After randomization, a MULTIMODAL CT will be performed to select treatment patient
Sponsors
Germans Trias i Pujol Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Outcomes Assessor)
Masking description
A blinded neurologist investigator (M. Gomis) will perform the clinical assesment of included patients at 90 days in outpatient clinics
Intervention model description
Patients will be included consecutively and randomized (1:1) to Multimodal MR or Multimodal CT stratifying by age (\<70, ≥70), stroke severity (NIHSS\<18, ≥18) and time from onset to hospital (\<8 hours, ≥8 hours)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Age ≥ 18 years old 2. Without previous functional dependency evaluated by modified Rankin Score ≤2 3. Regarding stroke severity (NIHSS≥ 6) 4. Time from symptoms onset \<24 hours
Exclusion criteria
1. Clinical suspicion of vertebrobasilar occlusion (brainstem symptoms) 2. MR contraindication or lack of concomitant availability of one or both neuroimaging techniques 3. Severe kidney failure
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| To evaluate long-term clinical outcome in ischemic stroke patients, and those treated with EVT and selected by each multimodal technique | 90 days | Modified Rankin Scale (mRS) ordinal distribution in each group. The mRS measures the patient functional status. It range from 0 to 6, and the values are (0, 1, 2, 3, 4, 5 and 6). The 0 value indicate a patient completely functional independent and without neurological deficit and 6 value indicate death. The value 1 indicate a minor neurological deficit but the patient is fully independent, the value 2 indicate that the patient do not perform all his activities (like work) but is fully independent for the daily activities so can live alone without assistance, value 3 indicates a patient partially dependent taht can not live alone during more than a week, value 4 indicates a patient totally dependent in a wheelchair but able to be some hours without assistance, and value 5 indicates a patient totally dependent in bed. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| To evaluate the rate of symptomatic intracerebral haemorrhage in ischemic stroke patients, and those treated with EVT and selected by each multimodal technique | 24-36 hours after stroke | To compare the rate of symptomatic intracranial haemorrhage |
| To evaluate mortality in ischemic stroke patients, and those treated with EVT and selected by each multimodal technique | 7-90 days after stroke | To compare mortality at 7 days and 90 days |
| To evaluate the presence of vomiting during the acquisition technique in ischemic stroke patients, and those treated with EVT and selected by each multimodal technique | At 24 hours after stroke | To compare vomiting during the acquisition technique time |
| To evaluate long-term good clinical outcome in ischemic stroke patients, and those treated with EVT and selected by each multimodal technique | 90 days | Modified Rankin Scale (mRS\<3) in each group. The mRS measures the patient functional status. It range from 0 to 6, and the values are (0, 1, 2, 3, 4, 5 and 6). The 0 value indicate a patient completely functional independent and without neurological deficit and 6 value indicate death. The value 1 indicate a minor neurological deficit but the patient is fully independent, the value 2 indicate that the patient do not perform all his activities (like work) but is fully independent for the daily activities so can live alone without assistance, value 3 indicates a patient partially dependent taht can not live alone during more than a week, value 4 indicates a patient totally dependent in a wheelchair but able to be some hours without assistance, and value 5 indicates a patient totally dependent in bed. |
| Indication of EVT in each technique | Through study completion, approximately 1 year | Rate of ischemic stroke patients selected for endovascular treatment by each technique |
| Feasibility of multimodal neuroimaging to select patients for EVT | Through study completion, approximately 1 year | Door-picture time and door-groin puncture time in each technique and movement artifacts |
| To evaluate the presence of in-hospital pneumonia in ischemic stroke patients, and those treated with EVT and selected by each multimodal technique | During hospitalization after stroke (approximately 7 days) | To compare the rate of in-hospital pneumonia |
Countries
Spain
Outcome results
None listed